Skip to main content

Find Clinical Trials

Home
Conditions
Diabetes Insipidus, Nephrogenic

Clinical trial condition

Diabetes Insipidus, Nephrogenic

Explore clinical trials studying Diabetes Insipidus, Nephrogenic. Study availability and eligibility vary by location and protocol.

9 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Diabetes Insipidus, Nephrogenic trial results

Recruiting

National Registry of Rare Kidney Diseases

NCT06065852

Conditions: AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis, +207 more
Locations: Zoe Plummer Bristol, South West, United Kingdom

View Trial Details

Not Yet Recruiting

Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children

NCT06604975

Conditions: Behavior, Behavioral Symptoms, Central Diabetes Insipidus, +18 more
Locations: CHU Angers Angers, France

CHU de Bordeaux Bordeaux, France

CHU Lille Lille, France

HCL Lyon, France

View all 14 locations

View Trial Details

Completed

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

NCT05190744

Conditions: Abnormalities, Multiple, Acquired Nephrogenic Diabetes Insipidus, Autosomal Dominant Polycystic Kidney Disease, +19 more
Locations: Mayo Clinic Jacksonville, Florida, United States

View Trial Details

Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions: 3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations: CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium

View Trial Details

Completed

Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the ICU: a Retrospective Analysis

NCT04939753

Conditions: Diabetes Insipidus, Diabetes Insipidus, Nephrogenic, Female Urogenital Diseases, +6 more
Locations: UZ Brussel Jette, Brussels Capital, Belgium

View Trial Details

Completed

Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus

NCT02967653

Conditions: Diabetes Insipidus, Diabetes Insipidus, Nephrogenic, Female Urogenital Diseases, +6 more
Locations: McGill University Health Centre Montreal, Quebec, Canada

Jewish General Hospital Montreal, Quebec, Canada

Douglas Mental Health University Institute Montreal, Quebec, Canada

View Trial Details

Completed

Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus

NCT00478335

Conditions: Diabetes Insipidus, Diabetes Insipidus, Nephrogenic, Female Urogenital Diseases, +11 more
Locations: University of Colorado at Denver and Health Sciences Center Aurora, Colorado, United States

University of Aarhus Aarhus, Denmark

View Trial Details

Completed

Vasopressin and V2 Receptor in Meniere's Disease

NCT00599560

Conditions: Diabetes Insipidus, Diabetes Insipidus, Nephrogenic, Ear Diseases, +12 more
Locations: Department of Otolaryngology, Osaka University, School of Medicine Suita, Osaka, Japan

View Trial Details

Completed

Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus

NCT00004360

Conditions: Diabetes Insipidus, Diabetes Insipidus, Nephrogenic, Disease Attributes, +11 more
Locations: Not specified

View Trial Details